StocksMedium•21 October 2026•
1 min read
Abbott to Spin Off Global Nutrition Business into Independent Public Company by 2027
Key Facts
1Abbott intends to separate its Nutrition business into an independent, publicly traded company by the end of 2027.
2The Nutrition business has approximately $8.5 billion in annual sales and includes brands like Similac and Ensure.
3The separation is intended to be a tax-free distribution to Abbott shareholders.
Abbott announced its intention to separate its Nutrition business into an independent, publicly traded company by the end of 2027. According to a statement on PR Newswire, the separation is intended to be executed through a tax-free distribution of shares to Abbott shareholders, allowing both entities to pursue specialized growth strategies.
The Nutrition business generates approximately $8.5 billion in annual sales and includes major brands such as Similac and Ensure. Shares of ABT closed at $102.45 on October 20, 2026, after trading between a session low of $100.75 and a high of $105.62.